Respiratory manifestations are frequently overlooked as a primary presenting symptom of systemic diseases. This review explores the diverse respiratory complications associated with hematologic, endocrine and metabolic, renal, and gastrointestinal disorders. We delve into the pathophysiological mechanisms underlying these respiratory manifestations, emphasizing the importance of recognizing these connections for accurate diagnosis and optimal patient management.
The respiratory system is intricately connected to other organ systems within the human body. Consequently, various systemic diseases can manifest with significant respiratory symptoms, often complicating diagnosis and management. This review aims to provide a comprehensive overview of respiratory manifestations associated with a range of systemic disorders, highlighting their clinical significance and implications for patient care.
Anemias: Iron deficiency anemia can present with dyspnea and fatigue due to decreased oxygen-carrying capacity. Anemia of chronic disease can lead to exertional dyspnea and impaired gas exchange.
Hemoglobinopathies: Sickle cell disease can manifest with acute chest syndrome, a potentially life-threatening complication characterized by pulmonary infiltrates, fever, and respiratory distress.
Leukemias and Lymphomas: Infiltration of the lungs by leukemic cells or lymphoma can cause respiratory symptoms such as cough, dyspnea, and chest pain.
Thrombocytopenia: Can lead to spontaneous pulmonary hemorrhage.
Coagulation Disorders: Can predispose to pulmonary embolism, a life-threatening condition.
Diabetes Mellitus: Can lead to diabetic ketoacidosis, resulting in Kussmaul respirations (deep and rapid breathing). Diabetic neuropathy can affect respiratory muscles, leading to weakness and respiratory insufficiency.
Hypothyroidism: Can cause hypoventilation and respiratory muscle weakness.
Hyperthyroidism: Can lead to tachypnea, dyspnea, and atrial fibrillation with subsequent heart failure.
Obesity: Can contribute to obstructive sleep apnea and hypoventilation syndrome.
Chronic Kidney Disease: Can lead to pulmonary edema due to fluid overload and left ventricular dysfunction. Uremic toxins can also accumulate in the lungs, causing pulmonary edema and restrictive lung disease.
Acute Kidney Injury: Can result in pulmonary edema and acute respiratory distress syndrome (ARDS).
Gastroesophageal Reflux Disease (GERD): Can cause aspiration pneumonia and chronic cough.
Celiac Disease: Can present with pulmonary manifestations such as bronchiectasis and interstitial lung disease.
Liver Cirrhosis: Can lead to ascites, hepatic encephalopathy, and hepatopulmonary syndrome.
Early Recognition: Recognizing the respiratory manifestations of systemic diseases is crucial for timely diagnosis and appropriate management.
Multidisciplinary Approach: A multidisciplinary approach involving pulmonologists, hematologists, endocrinologists, nephrologists, and other specialists is essential for optimal patient care.
Thorough Investigations: A comprehensive evaluation, including history, physical examination, pulmonary function tests, imaging studies (chest X-ray, CT scan), and laboratory investigations, is crucial for accurate diagnosis.
Treatment: Treatment should focus on addressing the underlying systemic disorder while managing the respiratory complications.
Respiratory manifestations are a common feature of various systemic diseases. Recognizing these connections is crucial for accurate diagnosis and appropriate management. A multidisciplinary approach and thorough investigations are essential for optimal patient care. Further research is needed to better understand the pathophysiology of these respiratory complications and develop novel therapeutic strategies.
1.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
2.
A new theranostic drug targets different cancer types.
3.
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
4.
Investigations may result in novel combination therapies for early-stage lung cancers.
5.
A better option for mild to moderate depression?
1.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
2.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
3.
Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma
4.
Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XVI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation